Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Analysis

Editor-in-Chief

ISSN (Print): 1573-4129
ISSN (Online): 1875-676X

Back
Research Article

Validation of Ultra Performance Liquid Chromatography-Tandem Mass Spectrometry Coupled with Electrospray Ionization Method for Quantitative Determination of Ornidazole in Solid Dispersion

Author(s): Gopal Prasad Agrawal*, Rajesh Kumar Maheshwari and Pradeep Mishra

Volume 16, Issue 5, 2020

Page: [487 - 493] Pages: 7

DOI: 10.2174/1573412914666181024145937

Price: $65

Abstract

Background and Objective: The present study describes the UPLC-MS/MS method validation for the analysis of ornidazole in solid dispersion.

Methods: The proposed UPLC-MS/MS method utilizes BEH Shield RP18 column (2.1 mm 100 mm, 1.7 μm) with a gradient programmed mobile phase composed of water and acetonitrile at a flow rate of 0.4 mL/min which varies with time program. Ornidazole was detected by UPLC-MS/MS with three proton adducts at m/z 82.04, 128.05 as daughter ions and 220.03 as a parent ion in Multiple Reaction Monitoring (MRM) operated in positive mode.

Results: Adducts at m/z 128.05 was found to be the most stable and showed higher intensity was selected for quantification of ornidaozle in solid dispersion. In the method, validation linearity was determined at concentration range of 10-100ng/mL and a correlation coefficient was found (r2) ≥0.9994. The limit of detection and limit of quantification were found to be 1.5 and 4 ng/mL, respectively. Inter and Intra-day precision was found within 0.33 and 0.11% and accuracy within 100.08% and 100.04%.

Conclusion: A sensitive and selective UPLC-MS/MS method had been validated for the analysis of ornidazole in solid dispersion. The proposed method of analysis of ornidazole in solid dispersion can be used in quality control laboratories.

Keywords: UPLC-MS/MS, ornidazole, solid dispersion, method validation, ESI, hydrotropic agents.

« Previous Next »
Graphical Abstract

[1]
Hizarciolu, S.Y.; Zeynep, A.Y.; Özyazici, M. Bioavailability file: Ornidazole. Fabad J. Pharm. Sci., 2004, 29, 133-144.
[2]
Margaret, A.P.; Samuel, L.S. Goodman and Gilman’s The Pharmacological Basis of Therapeutics: Chemotherapy of protozoal infections, 11th ed; McGraw Hill Medical Publishing Division: New Delhi, 2006.
[3]
Singh, P.; Mittal, R.; Sharma, G.C.; Singh, S.; Singh, A. Profiles of Drug Substances, Excipients and Related Methodology; Ornidazole. Comprehensive Profile, 2003, 30, 123-184.
[4]
Reynolds, J.E.F. Martindale, The Extra Pharmacopoeia, 32nd ed; Royal Pharmaceutical Society: London, 1996.
[5]
Kumar Maheshwari, R.; Indurkhya, A. Formulation and evaluation of aceclofenac injection made by mixed hydrotropic solubilization technique. Iran. J. Pharm. Res., 2010, 9(3), 233-242.
[PMID: 24363732]
[6]
Rao, M.G.; Suneetha, R.; Sudhakara, P.; Reddy, S.; Ravi, T.K. Preparation and evaluation of solid dispersions of naproxen. Indian J. Pharm. Sci., 2005, 67, 26-29.
[7]
Chepurwar, S.B.; Shirkhedkar, A.A.; Bari, S.B.; Fursule, R.A.; Surana, S.J. Validated HPTLC method for simultaneous estimation of levofloxacin hemihydrate and ornidazole in pharmaceutical dosage form. J. Chromatogr. Sci., 2007, 45(8), 531-536.
[http://dx.doi.org/10.1093/chromsci/45.8.531] [PMID: 18019564]
[8]
Patel, S.A.; Prajapati, A.M.; Patel, P.U.; Patel, N.J.; Vaghmasi, J.B. Development and validation of column high-performance liquid chromatographic and derivative spectrophotometric methods for determination of levofloxacin and ornidazole in combined dosage forms. J. AOAC Int., 2008, 91(4), 756-761.
[http://dx.doi.org/10.1093/jaoac/91.4.756] [PMID: 18727534]
[9]
Suhagia, B.N.; Shah, S.A.; Rathod, I.S.; Patel, H.M.; Shah, D.R.; Marolia, B.P. Determination of gatifloxacin and ornidazole in tablet dosage forms by high-performance thin-layer chromatography. Anal. Sci., 2006, 22(5), 743-745.
[http://dx.doi.org/10.2116/analsci.22.743] [PMID: 16770055]
[10]
Gandhimati, M.; Ravi, T.K.; Sukla, N. Validated high performance thin layer chromatographic method for simultaneous estimation of oflxacin and Ornidazole in tablet dosage form. Indian J. Pharm. Sci., 2006, 68, 838-840.
[http://dx.doi.org/10.4103/0250-474X.31033]
[11]
Puranik, M.; Bhawsar, D.V.; Rathi, P.; Yeole, P.G. Simultaneous determination of ofloxacin and ornidazole in solid dosage form by RP-HPLC and HPTLC Techniques. Indian J. Pharm. Sci., 2010, 72(4), 513-517.
[http://dx.doi.org/10.4103/0250-474X.73937] [PMID: 21218068]
[12]
See, K.L.; Elbashir, A.A.; Saad, B.; Ali, A.S.M.; Aboul-Enein, H.Y. Simultaneous determination of ofloxacin and ornidazole in pharmaceutical preparations by capillary zone electrophoresis. Biomed. Chromatogr., 2009, 23(12), 1283-1290.
[http://dx.doi.org/10.1002/bmc.1251] [PMID: 19488980]
[13]
Ranjane, P.N.; Gandhi, S.V.; Kadukar, S.S.; Ranher, S.S. Simultaneous determination of cefuroxime axetil and ornidazole in tablet dosage form using reversed-phase high performance liquid chromatography. Se Pu, 2008, 26(6), 763-765.
[http://dx.doi.org/10.1016/S1872-2059(08)60033-4] [PMID: 19253561]
[14]
Groppi, A.; Papa, P.; Montagna, M.; Carosi, G. Determination of ornidazole in human plasma and red blood cells using high-performance liquid chromatography. J. Chromatogr. A, 1986, 380(2), 437-442.
[http://dx.doi.org/10.1016/S0378-4347(00)83676-2] [PMID: 3760074]
[15]
Heizmann, P.; Geschke, R.; Zinapold, K. Determination of ornidazole and its main metabolites in biological fluids. J. Chromatogr. A, 1990, 534, 233-240.
[http://dx.doi.org/10.1016/S0378-4347(00)82168-4] [PMID: 2094712]
[16]
Soma, S.; Vidyasagan, V.; Narsaiah, N.; Anand, R.K. Validated HPLC method for determination of ornidazole in human serum and urine. Indian J. Pharm. Sci., 2005, 67, 302-306.
[17]
Khattab, F.I.; Ramadan, N.K.; Hegazy, M.A.; Ghoniem, N.S. Stability-indicating methods for the determination of ornidazole in the presence of its degradate according to ICH Guidelines. Pharm. Anal. Acta, 2012, 3, 1-8.
[http://dx.doi.org/10.4172/2153-2435.1000179]
[18]
Jiangbo, D.; Pan, D.; Xiaoyan, C.; Tiangeng, Y.; Dafang, Z. Characterization of ornidazole metabolites in human bile after intraveneous doses by ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry. Acta Pharm. Sin. B, 2012, 2, 159-167.
[http://dx.doi.org/10.1016/j.apsb.2012.01.002]
[19]
Du, J.; Ma, Z.; Zhang, Y.; Wang, T.; Chen, X.; Zhong, D. Simultaneous determination of ornidazole and its main metabolites in human plasma by LC-MS/MS: application to a pharmacokinetic study. Bioanalysis, 2014, 6(18), 2343-2356.
[http://dx.doi.org/10.4155/bio.14.117] [PMID: 25384588]
[20]
Nováková, L.; Matysová, L.; Solich, P. Advantages of application of UPLC in pharmaceutical analysis. Talanta, 2006, 68(3), 908-918.
[http://dx.doi.org/10.1016/j.talanta.2005.06.035] [PMID: 18970409]
[21]
Wren, S.A.; Tchelitcheff, P. Use of ultra-performance liquid chromatography in pharmaceutical development. J. Chromatogr. A, 2006, 1119(1-2), 140-146.
[http://dx.doi.org/10.1016/j.chroma.2006.02.052] [PMID: 16564533]
[22]
Harmita, Suryadi H. Setiawati, A; Damayanti, D. Development and validation of a method for simultaneous quantification of seven water-soluble vitamins in pediatrics syrup by UPLC-MS/MS. Curr. Pharm. Anal., 2018, 14, 23-34.
[23]
Shammout, M.J.A.; Basci, N.E. Validated ultra performance liquid chromatography-tandem mass spectrometric method for determination of betamethasone or dexamethasone in pharmaceuticals. Curr. Pharm. Anal., 2018, 14, 68-75.
[24]
ICH Guideline Validation of Analytical Procedures. Text and Methodology Q2 (R1), ICH Harmonized Tripartite GuidelineInternational Conference on Harmonization; Geneva, Switzerland, 2005.
[25]
Agrawal, G.P.; Maheshwari, R.K.; Mishra, P. Preparation of solid dispersions of ornidazole using mixed hydrotropic solubilization technique and their characterization. Int. J. Green Pharm., 2017, 11, S715-S720.

Rights & Permissions Print Cite
Article Metrics
3
1
© 2024 Bentham Science Publishers | Privacy Policy